News

For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...
Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...
Glucagon-like peptide-1 (GLP-1) is a hormone that is naturally produced by the body and which helps regulate blood sugar ...
For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...
Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
Accepting the bioequivalence study report, the Subject Expert Committee (SEC) functional under the Central Drugs Standard ...
Researchers at Syracuse University have identified a brain peptide, TDN, that effectively curbs appetite and enhances glucose ...
(HealthDay News) — A considerable proportion of adolescents and young adults eligible for glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are uninsured, and many young adults do not have a ...
Promising medication given before surgery could improve surgical outcomes and reduce healthcare burdens associated with obesity.
Fat jabs could soon be available over the counter at pharmacies without the need for a GP, according to rppeorts. Fat jabs ...
A UK government and Eli Lilly £85 million program will expand obesity care nationwide, offering digital, community, and ...